These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 11709086)

  • 21. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A PTEN-like phosphatase with a novel substrate specificity.
    Pagliarini DJ; Worby CA; Dixon JE
    J Biol Chem; 2004 Sep; 279(37):38590-6. PubMed ID: 15247229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.
    Schmid AC; Woscholski R
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):348-9. PubMed ID: 15046606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I-proteins - a proposed switch in myotubularin function.
    Clague MJ; Dove SK; Barr FA
    Trends Biochem Sci; 2004 Feb; 29(2):58-61. PubMed ID: 15102431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.
    Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
    Maehama T; Okahara F; Kanaho Y
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
    Backers K; Blero D; Paternotte N; Zhang J; Erneux C
    Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel class of PTEN protein in Arabidopsis displays unusual phosphoinositide phosphatase activity and efficiently binds phosphatidic acid.
    Pribat A; Sormani R; Rousseau-Gueutin M; Julkowska MM; Testerink C; Joubès J; Castroviejo M; Laguerre M; Meyer C; Germain V; Rothan C
    Biochem J; 2012 Jan; 441(1):161-71. PubMed ID: 21864294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
    Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM
    Gastroenterology; 2002 Oct; 123(4):1163-78. PubMed ID: 12360479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.
    Orchiston EA; Bennett D; Leslie NR; Clarke RG; Winward L; Downes CP; Safrany ST
    J Biol Chem; 2004 Jan; 279(2):1116-22. PubMed ID: 14561749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
    Seminario MC; Wange RL
    Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling pathways of D3-phosphoinositide-binding kinases in T cells and their regulation by PTEN.
    Seminario MC; Wange RL
    Semin Immunol; 2002 Feb; 14(1):27-36. PubMed ID: 11884228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TPIP: a novel phosphoinositide 3-phosphatase.
    Walker SM; Downes CP; Leslie NR
    Biochem J; 2001 Dec; 360(Pt 2):277-83. PubMed ID: 11716755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
    Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity.
    Caffrey JJ; Darden T; Wenk MR; Shears SB
    FEBS Lett; 2001 Jun; 499(1-2):6-10. PubMed ID: 11418101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.